Litcius/Paper detail

N6-methyladenosine-associated prognostic pseudogenes contribute to predicting immunotherapy benefits and therapeutic agents in head and neck squamous cell carcinoma

Liqiang Tan, Yali Qin, Ruiling Xie, Tianliang Xia, Xiaotong Duan, Lan Peng, Rui You, You‐Ping Liu, Xiong Zou, Mengxia Zhang, Mei Lin, Ming‐Yuan Chen

2022Theranostics20 citationsDOIOpen Access PDF

Abstract

A-associated prognostic pseudogenes significantly contribute to predicting immunotherapy benefits and therapeutic agents, which might bring some potential implications for both immunotherapy and chemotherapy in HNSCC.

Topics & Concepts

PseudogeneBiologyHead and neck squamous-cell carcinomaCancer researchImmune systemImmunotherapyGeneOncogeneCancerImmunologyCell cycleGenomeGeneticsHead and neck cancerRNA modifications and cancerCancer-related gene regulationCancer-related molecular mechanisms research
N6-methyladenosine-associated prognostic pseudogenes contribute to predicting immunotherapy benefits and therapeutic agents in head and neck squamous cell carcinoma | Litcius